FDA will convene a one-day, in-person and virtual public workshop, “Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine ,” on Tuesday, Dec. 16, 2025 (1). The workshop is ...
Gain leadership and innovation insights from CEO of the Year finalist at 2025 CPHI Pharma Awards, Mahler Hanns-Christian, who ...
The CNPV pilot program significantly reduces review times, but may challenge safety standards and resource allocation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback